BioCryst Pharmaceuticals
BCRX
#4613
Rank
NZ$4.10 B
Marketcap
NZ$16.13
Share price
-0.43%
Change (1 day)
13.92%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -NZ$0.8 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.88 Billion. In 2025 the company made an earning of NZ$0.46 Billion, an increase over its 2024 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.8 Billion-271.56%
2025 NZ$0.46 B-407.51%
2024 -NZ$0.16 Billion-61.56%
2023 -NZ$0.4 Billion-7.43%
2022 -NZ$0.43 Billion34.42%
2021 -NZ$0.32 Billion-0.55%
2020 -NZ$0.32 Billion67.88%
2019 -NZ$0.19 Billion7.55%
2018 -NZ$0.18 Billion53.92%
2017 -NZ$0.12 Billion19.29%
2016 -NZ$95.26 Million28.19%
2015 -NZ$74.32 Million-4.8%
2014 -NZ$78.06 Million50.09%
2013 -NZ$52.01 Million-23.29%
2012 -NZ$67.81 Million-26.19%
2011 -NZ$91.86 Million54.78%
2010 -NZ$59.35 Million150.1%
2009 -NZ$23.73 Million-49.43%
2008 -NZ$46.93 Million14.07%
2007 -NZ$41.14 Million-49.31%
2006 -NZ$81.16 Million72.87%
2005 -NZ$46.95 Million22.08%
2004 -NZ$38.46 Million75.3%
2003 -NZ$21.94 Million-25.36%
2002 -NZ$29.4 Million225.05%
2001 -NZ$9.05 Million-56.6%
2000 -NZ$20.84 Million50.63%
1999 -NZ$13.84 Million38.05%
1998 -NZ$10.02 Million-52.46%
1997 -NZ$21.08 Million58.44%
1996 -NZ$13.31 Million-14.44%
1995 -NZ$15.55 Million28.57%
1994 -NZ$12.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$18.53 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.29 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$42.26 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.12 Billion-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.54 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.98 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$38.34 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA